FIKKAN PHARMA AS
Fikkan Pharma
A consulting company in the international pharma industry.
Links
Organization
- CEO
- JF
Jan Fikkan1954
- Chairman of the board
- JF
Jan Fikkan1954
- Years since formation
- 10 years
- since Mar 6, 2015
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2024
- 666,321
- NOK
- Annual total result 2024
- 958,797
- NOK
- Total equity 2024
- 2,535,731
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
JF 1954 | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
JF 1954 | Chairman | 100 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
JF 1954 | Managing Director/CEO, Chairman | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
JF 1954 | Ordinary shares | 30,000 | 100 % |
Shares owned by the FIKKAN PHARMA AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| NO0010852213 | 173,890 | 0.27 % | |
| Ordinary shares | 567 | 0.05 % | |
| NO0010765001 | 515 | 0.04 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 666,321 | 856,749 | 668,468 | 346,143 |
Annual Total Result | 958,797 | 594,106 | 409,581 | 142,867 |
Total assets | 2,770,046 | 1,895,616 | 2,096,593 | 1,597,337 |
Total liabilities | 234,315 | 318,682 | 234,265 | 144,591 |
Total equity | 2,535,731 | 1,576,934 | 1,862,328 | 1,452,746 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 666,321 | 856,749 | 668,468 | 346,143 |
Total operating costs | 157,794 | 160,022 | 144,052 | 158,472 |
Operating result | 508,527 | 696,727 | 524,416 | 187,671 |
Financial income/costs | 565,496 | 49,844 | 669 | -3,822 |
Profit before tax | 1,074,023 | 746,571 | 525,085 | 183,849 |
Total tax & extraordinary income/cost | 115,226 | 152,465 | 115,504 | 40,982 |
Annual Total Result | 958,797 | 594,106 | 409,581 | 142,867 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 1,188,504 | 1,241,881 | 1,095,680 | 1,043,126 |
Total current assets | 1,581,542 | 653,735 | 1,000,913 | 554,211 |
Total assets | 2,770,046 | 1,895,616 | 2,096,593 | 1,597,337 |
Short term debt | 234,315 | 318,682 | 234,265 | 144,591 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 234,315 | 318,682 | 234,265 | 144,591 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 |
Retained earnings | 2,505,731 | 1,546,934 | 1,832,328 | 1,422,746 |
Total equity | 2,535,731 | 1,576,934 | 1,862,328 | 1,452,746 |
Total equity and liabilities | 2,770,046 | 1,895,616 | 2,096,593 | 1,597,337 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises